<DOC>
	<DOC>NCT00948818</DOC>
	<brief_summary>The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with irritable bowel syndrome with constipation (IBS-C). The primary efficacy parameter is the percentage of patients in each treatment group that meet the protocol definition for Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder.</brief_summary>
	<brief_title>Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Patient meets protocol criteria for IBS: reports abdominal discomfort or pain that has two or more of the following three features: 1. Relieved with defecation 2. Onset associated with a change in frequency of stool 3. Onset associated with a change in form (appearance) of stool Patient reports &lt; 3 bowel movements (BMs) per week (in the absence of any laxative, suppository, or enema use during the preceding 24 hours) and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during &gt; 25% of BMs Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12lead ECG, or clinical laboratory tests (some patients may require a colonoscopy per American Gastroenterological Association (AGA) guidelines) Patient is compliant with Interactive Voice Response System (IVRS) for daily diary reporting of BM habits and IBS symptoms Patient has history of loose or watery stools for &gt;25% of BMs Patient has a structural abnormality of the gastrointestinal (GI) tract or a history of a disease or condition that can affect GI motility Patient has any protocolexcluded or clinically significant medical or surgical history or concomitant medication use that could confound the study assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Constipation</keyword>
	<keyword>Linaclotide</keyword>
</DOC>